GARDASIL has not been evaluated for carcinogenic potential.
GARDASIL has not been evaluated for genotoxic potential.
The safety and efficacy of GARDASIL have not been evaluated in children younger than 9 years.
Use with Other Vaccines
Results from clinical studies indicate that GARDASIL may be administered concomitantly (at a separate injection site) with hepatitis B vaccine (recombinant). GARDASIL has not been studied in clinical trials with other vaccines.
If you can spare a few dollars for the creators of this website to continue their research to bring you more great content, any amount, no matter how great or small, would be greatly appreciated.